NOVELIX PHARMACEUTICALS LIMITE | Small-cap | Healthcare
₹39.90
-5.00%
| NOVELIX Stock Comparison:
NOVELIX vs Entero HealthcareNOVELIX vs Amwill Health CareNOVELIX vs Royal SenseNOVELIX vs TrimurthiNOVELIX vs Zenlabs EthicaNOVELIX vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 208.6M
Gross Profit 5.8M 2.77%
Operating Income 2.1M 1.01%
Net Income 1.6M 0.77%

Balance Sheet Metrics

Total Assets 272.1M
Total Liabilities 96.7M
Shareholders Equity 175.4M
Debt to Equity 0.55

Cash Flow Metrics

Revenue & Profitability Trend

NOVELIX Income Statement From 2024 to 2025

Metric20252024
Revenue i307.2M42.2M
Cost of Goods Sold i295.7M38.4M
Gross Profit i11.4M3.9M
Gross Margin % i3.7%9.2%
Operating Expenses
Research & Development i--
Selling, General & Administrative i-1.0M
Other Operating Expenses i9.3M2.2M
Total Operating Expenses i9.3M3.3M
Operating Income i1.1M-1.5M
Operating Margin % i0.3%-3.5%
Non-Operating Items
Interest Income i-2.0M
Interest Expense i--
Other Non-Operating Income--
Pre-tax Income i1.2M212.6K
Income Tax i388.0K108.4K
Effective Tax Rate % i31.5%51.0%
Net Income i845.0K104.1K
Net Margin % i0.3%0.2%
Key Metrics
EBITDA i1.5M-748.2K
EPS (Basic) i-₹0.01
EPS (Diluted) i-₹0.01
Basic Shares Outstanding i-8100000
Diluted Shares Outstanding i-8100000

Income Statement Trend

NOVELIX Balance Sheet From 2024 to 2025

Metric20252024
Assets
Current Assets
Cash & Equivalents i6.8M1.2M
Short-term Investments i70.2M25.0M
Accounts Receivable i181.4M133.6K
Inventory i8.4M11.9M
Other Current Assets2.5M-
Total Current Assets i269.3M41.3M
Non-Current Assets
Property, Plant & Equipment i1.9M0
Goodwill i0100
Intangible Assets i-100
Long-term Investments--
Other Non-Current Assets--
Total Non-Current Assets i2.7M32.4M
Total Assets i272.1M73.6M
Liabilities
Current Liabilities
Accounts Payable i93.0M30.0K
Short-term Debt i0-
Current Portion of Long-term Debt--
Other Current Liabilities1.0K71.3K
Total Current Liabilities i96.7M101.4K
Non-Current Liabilities
Long-term Debt i0-
Deferred Tax Liabilities i00
Other Non-Current Liabilities-1.0K-
Total Non-Current Liabilities i-1.0K0
Total Liabilities i96.7M101.4K
Equity
Common Stock i99.5M81.0M
Retained Earnings i--24.1M
Treasury Stock i--
Other Equity--
Total Shareholders Equity i175.4M73.5M
Key Metrics
Total Debt i00
Working Capital i172.7M41.2M

Balance Sheet Composition

NOVELIX Cash Flow Statement From 2024 to 2025

Metric20252024
Operating Activities
Net Income i1.2M212.6K
Depreciation & Amortization i--
Stock-Based Compensation i--
Working Capital Changes i-222.4M-440.0K
Operating Cash Flow i-221.3M-2.3M
Investing Activities
Capital Expenditures i-1.1M184.6K
Acquisitions i--
Investment Purchases i--
Investment Sales i30.2M-
Investing Cash Flow i29.1M184.6K
Financing Activities
Share Repurchases i--
Dividends Paid i--
Debt Issuance i--
Debt Repayment i--
Financing Cash Flow i113.2M-
Free Cash Flow i-136.9M-3.4M
Net Change in Cash i-79.1M-2.1M

Cash Flow Trend

NOVELIX Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 514.50
Price to Book 2.34
Price to Sales 1.73

Profitability Ratios

Profit Margin 0.28%
Operating Margin 1.01%
Return on Equity 0.68%
Return on Assets 0.45%

Financial Health

Current Ratio 2.79
Debt to Equity 0.00
Beta 0.32

Per Share Data

EPS (TTM) ₹0.08
Book Value per Share ₹17.59
Revenue per Share ₹30.92

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
novelix532.4M514.502.340.68%0.28%0.00
Entero Healthcare 51.9B54.823.015.36%1.90%21.76
Amwill Health Care 1.2B8.971.7224.85%26.44%0.00
Royal Sense 1.1B17.333.6227.55%10.26%11.74
Trimurthi 264.8M102.352.400.00%1.85%-
Zenlabs Ethica 214.6M78.021.992.62%0.52%121.85

Financial data is updated regularly. All figures are in the company's reporting currency.